Researchers have found a warning letter from all the way back in 2006 that the FDA’s parent agency Health and Human services had warned the makers of the now-recalled heart medication back in 2006 of problems with their manufacturing facility. Specifically citing Digitek (as Digoxin) along with other substances produced at their New Jersey facility, the letter note a specific lack of oversight as regards product strength. Now we know that the pills were almost 2 times the size they should have been and we are hearing from a lot of patients about the serious injuries they suffered while on the bad pill. Many first learn of the problem when the get the recall letter from their pharmacy. Wal Mart and Walgreen’s have obviously sent out a lot of such letters.
Comments are closed.